BIOMAT Database Logo BIOMAT Database Logo

[Effect of antithrombin III concentrate infusion therapy on congenital antithrombin III deficiency]. 1984

S Kusumi, and M Kobayashi, and N Takata, and F Imanaka, and S Maehama, and Y Taketomi, and K Fujimura, and A Kuramoto

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008297 Male Males
D001796 Blood Protein Disorders Hematologic diseases caused by structural or functional defects of BLOOD PROTEINS. Blood Protein Disorder,Disorder, Blood Protein,Disorders, Blood Protein,Protein Disorder, Blood,Protein Disorders, Blood
D001797 Blood Protein Electrophoresis Electrophoresis applied to BLOOD PROTEINS. Hemoglobin Electrophoresis,Electrophoresis, Blood Protein,Electrophoresis, Hemoglobin,Protein Electrophoresis, Blood
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I
D020152 Antithrombin III Deficiency An absence or reduced level of Antithrombin III leading to an increased risk for thrombosis. Antithrombin 3 Deficiency,Congenital Antithrombin III Deficiency,Deficiency, Antithrombin III,Hereditary Antithrombin Deficiency,Antithrombin 3 Deficiencies,Antithrombin III Deficiencies,Deficiencies, Antithrombin 3,Deficiencies, Antithrombin III,Deficiency, Antithrombin 3

Related Publications

S Kusumi, and M Kobayashi, and N Takata, and F Imanaka, and S Maehama, and Y Taketomi, and K Fujimura, and A Kuramoto
Prophylactic use of antithrombin III concentrate following surgery in congenital antithrombin III deficiency.
January 1987, Clinical and laboratory haematology,
S Kusumi, and M Kobayashi, and N Takata, and F Imanaka, and S Maehama, and Y Taketomi, and K Fujimura, and A Kuramoto
Antithrombin III concentrate. Thromboprophylaxis during pregnancy in a patient with congenital antithrombin III deficiency.
January 1986, Acta obstetricia et gynecologica Scandinavica,
S Kusumi, and M Kobayashi, and N Takata, and F Imanaka, and S Maehama, and Y Taketomi, and K Fujimura, and A Kuramoto
Monitoring plasma antithrombin-III levels during infusion of antithrombin-III concentrate.
October 1984, Thrombosis and haemostasis,
S Kusumi, and M Kobayashi, and N Takata, and F Imanaka, and S Maehama, and Y Taketomi, and K Fujimura, and A Kuramoto
Uses of antithrombin III concentrate in congenital and acquired deficiency states.
May 1998, Transfusion,
S Kusumi, and M Kobayashi, and N Takata, and F Imanaka, and S Maehama, and Y Taketomi, and K Fujimura, and A Kuramoto
[Therapy with antithrombin III concentrate].
January 1990, Haematologica,
S Kusumi, and M Kobayashi, and N Takata, and F Imanaka, and S Maehama, and Y Taketomi, and K Fujimura, and A Kuramoto
Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
September 1989, The American journal of medicine,
S Kusumi, and M Kobayashi, and N Takata, and F Imanaka, and S Maehama, and Y Taketomi, and K Fujimura, and A Kuramoto
[Congenital antithrombin III deficiency].
January 1998, Ryoikibetsu shokogun shirizu,
S Kusumi, and M Kobayashi, and N Takata, and F Imanaka, and S Maehama, and Y Taketomi, and K Fujimura, and A Kuramoto
[Congenital antithrombin III deficiency].
January 1996, Ryoikibetsu shokogun shirizu,
S Kusumi, and M Kobayashi, and N Takata, and F Imanaka, and S Maehama, and Y Taketomi, and K Fujimura, and A Kuramoto
[Congenital deficiency of antithrombin III].
January 1990, Haematologica,
S Kusumi, and M Kobayashi, and N Takata, and F Imanaka, and S Maehama, and Y Taketomi, and K Fujimura, and A Kuramoto
Antithrombin III concentrate: its catabolism in health and in antithrombin III deficiency.
September 1981, Scandinavian journal of clinical and laboratory investigation,
Copied contents to your clipboard!